These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


119 related items for PubMed ID: 11794420

  • 1. Sudden irreversible sensory-neural hearing loss in a patient with diabetes receiving amikacin as an antibiotic-heparin lock.
    Saxena AK, Panhotra BR, Naguib M.
    Pharmacotherapy; 2002 Jan; 22(1):105-8. PubMed ID: 11794420
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials.
    Zhao Y, Li Z, Zhang L, Yang J, Yang Y, Tang Y, Fu P.
    Am J Kidney Dis; 2014 Mar; 63(3):479-90. PubMed ID: 24125729
    [Abstract] [Full Text] [Related]

  • 6. Effect of ultra-low dose and standard heparin locks on early tunnelled dialysis catheter outcomes in low-risk dialysis patients.
    Renaud CJ, Lim EK, Tho SJ, Yeoh LY.
    Nephrology (Carlton); 2015 Feb; 20(2):85-90. PubMed ID: 25346031
    [Abstract] [Full Text] [Related]

  • 7. Sodium citrate 4% versus heparin as a lock solution in hemodialysis patients with central venous catheters.
    Yon CK, Low CL.
    Am J Health Syst Pharm; 2013 Jan 15; 70(2):131-6. PubMed ID: 23292266
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antibiotic lock solutions for the prevention of catheter-related bacteraemia in haemodialysis patients.
    Chow KM, Poon YL, Lam MP, Poon KL, Szeto CC, Li PK.
    Hong Kong Med J; 2010 Aug 15; 16(4):269-74. PubMed ID: 20683069
    [Abstract] [Full Text] [Related]

  • 11. Antibiotic-heparin lock: in vitro antibiotic stability combined with heparin in a central venous catheter.
    Vercaigne LM, Sitar DS, Penner SB, Bernstein K, Wang GQ, Burczynski FJ.
    Pharmacotherapy; 2000 Apr 15; 20(4):394-9. PubMed ID: 10772369
    [Abstract] [Full Text] [Related]

  • 12. Comparison of tissue plasminogen activator-antibiotic locks with heparin-antibiotic locks in children with catheter-related bacteraemia.
    Onder AM, Chandar J, Simon N, Diaz R, Nwobi O, Abitbol CL, Zilleruelo G.
    Nephrol Dial Transplant; 2008 Aug 15; 23(8):2604-10. PubMed ID: 18332071
    [Abstract] [Full Text] [Related]

  • 13. Influence of intralumenal and antibiotic-lock of vancomycin on the rate of catheter removal in the patients with permanent hemodialysis catheters.
    Beigi AA, Khansoltani S, Masoudpour H, Atapour AA, Eshaghian A, Khademi EF.
    Saudi J Kidney Dis Transpl; 2010 Jan 15; 21(1):54-8. PubMed ID: 20061693
    [Abstract] [Full Text] [Related]

  • 14. A Taurolidine-Citrate-Heparin Lock Solution Effectively Eradicates Pathogens From the Catheter Biofilm in Hemodialysis Patients.
    Zwiech R, Adelt M, Chrul S.
    Am J Ther; 2016 Jan 15; 23(2):e363-8. PubMed ID: 23665885
    [Abstract] [Full Text] [Related]

  • 15. Comparison of heparin to citrate as a catheter locking solution for non-tunneled central venous hemodialysis catheters in patients requiring renal replacement therapy for acute renal failure (VERROU-REA study): study protocol for a randomized controlled trial.
    Bruyère R, Soudry-Faure A, Capellier G, Binquet C, Nadji A, Torner S, Blasco G, Yannaraki M, Barbar SD, Quenot JP.
    Trials; 2014 Nov 19; 15():449. PubMed ID: 25409678
    [Abstract] [Full Text] [Related]

  • 16. The effect of heparinized catheter lock solutions on systemic anticoagulation in hemodialysis patients.
    Thomson PC, Morris ST, Mactier RA.
    Clin Nephrol; 2011 Mar 19; 75(3):212-7. PubMed ID: 21329631
    [Abstract] [Full Text] [Related]

  • 17. A randomized trial comparing gentamicin/citrate and heparin locks for central venous catheters in maintenance hemodialysis patients.
    Moran J, Sun S, Khababa I, Pedan A, Doss S, Schiller B.
    Am J Kidney Dis; 2012 Jan 19; 59(1):102-7. PubMed ID: 22088576
    [Abstract] [Full Text] [Related]

  • 18. Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution.
    Krishnasami Z, Carlton D, Bimbo L, Taylor ME, Balkovetz DF, Barker J, Allon M.
    Kidney Int; 2002 Mar 19; 61(3):1136-42. PubMed ID: 11849468
    [Abstract] [Full Text] [Related]

  • 19. Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study.
    Fernandez-Hidalgo N, Almirante B, Calleja R, Ruiz I, Planes AM, Rodriguez D, Pigrau C, Pahissa A.
    J Antimicrob Chemother; 2006 Jun 19; 57(6):1172-80. PubMed ID: 16597634
    [Abstract] [Full Text] [Related]

  • 20. Treatment of dialysis catheter-related Enterococcus bacteremia with an antibiotic lock: a quality improvement report.
    Peterson WJ, Maya ID, Carlton D, Estrada E, Allon M.
    Am J Kidney Dis; 2009 Jan 19; 53(1):107-11. PubMed ID: 18848379
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.